ARTL – artelo biosciences, inc. (US:NASDAQ)
Stock Stats
News
11/18
08:35 am
artl
High
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit [Yahoo! Finance]
11/18
08:30 am
artl
High
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit 
11/13
08:30 am
artl
High
Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
11/13
08:05 am
artl
Medium
Artelo Biosciences, Inc. (NASDAQ: ARTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/12
08:00 am
artl
Low
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
11/13
08:05 am
Reiterates
Buy
Buy
HC Wainwright
Medium
-9.8%
11/12
09:35 am
artl
Medium
Form 10-Q ARTELO BIOSCIENCES, INC. For: Sep 30
11/8
04:34 pm
artl
Low
Form DEF 14A ARTELO BIOSCIENCES, INC. For: Dec 19
11/8
04:33 pm
artl
Low
Form DEFA14A ARTELO BIOSCIENCES, INC.
11/8
04:31 pm
artl
Low
Form ARS ARTELO BIOSCIENCES, INC. For: Dec 31
Show more
Top News Gainers
6/21 Form EFFECT ARTELO BIOSCIENCES, INC. 284.3%
4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%
2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%
7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%
6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%
11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%
3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%
9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%
8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%
6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%
Top News Decliners
10/17 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 15 Filed by: Gorgas Gregory D. -21.0%
3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%
11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%
6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%
4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%
1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%
2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%
2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%
10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%
2/3 Artelo's [MarketWatch] -8.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3